Stay updated on Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.

Latest updates to the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating restricted access to the study record. This replaces the previously visible study content.SummaryDifference0.5%

- Check20 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study details with an access-denied screen.SummaryDifference18%

- Check27 days agoChange DetectedThe page footer now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6.SummaryDifference0.0%

- Check41 days agoChange DetectedThe revision tag on the page changed from v3.6.5 to v3.6.6. This indicates a new release of the page, with metadata updated but no substantive changes to study information or layout.SummaryDifference0.0%

- Check48 days agoChange DetectedA funding attribution for 2023 U.S. NIH Grant/Contract was added to the CTIS registry line of the study record, updating the funding source information associated with NCT03485209. This reflects an additional grant/contract year linked to the study.SummaryDifference0.0%

Stay in the know with updates to Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.